8. Johnson & Johnson
New Brunswick, NJ
www.jnj.com
Beauty Sales: $5.1 billion for skin care and baby care products.
Corporate Sales: $61 billion



Key Personnel: William C. Weldon, chairman and chief executive officer; Christine A. Poon, vice chairman; Colleen A. Goggins, worldwide chairman, consumer group.

Products/Brands: Personal care, skin care, baby care and sun care, including Aveeno, Clean & Clear, Johnson’s, Balmex, Neutrogena, Natusan, Piz Buin, Sundown, RoC, Shower to Shower.

New Products: Aveeno Positively Ageless anti-aging skin care line, Aveeno Continuous Action Sunblock Spray, ROC Retinol Correxion hand repair; Neutrogena Ageless Restoratives.

 Aveeno Positively Ageless is an anti-aging entry from J&J.
Comments: Chairman William C. Weldon stated that despite 2007 being “one of the most challenging years in recent memory,” the company achieved solid results. Worldwide sales grew to a record $61.1 billion, an increase of 14.6%, with operational sales up 11.5%. Net income, however, declined 4.3%. By division, skin care sales jumped nearly 16% to $3.1 billion. The company credited the gains to sun care, Clean & Clear, Aveeno and Neutrogena products. Last year, baby care sales rose nearly 14% to $2 billion. Acquired brands from Pfizer provided a boost.
  
For the first quarter of 2008, corporate sales rose 7.7% to $16.2 billion. The gain was attributed in part to strong sales of whitening and baby care products, and Neutrogena, Clean & Clear and Aveeno skin care products.
  
In July, Johnson & Johnson (China) Investment Co., Ltd. announced that it had acquired Beijing Dabao Cosmetics Co., Ltd. from Beijing Sanlu Factory and the Beijing Dabao Co. Ltd. Staff Shareholding Committee. Dabao’s skin care line includes products popular in Chinese households, such as Sod Milk and Beauty Day Cream.
  
In September, the UK’s Advertising Standards Agency requested that J&J discontinue its advertising for RoC CompleteLift face cream, saying that claims were unsubstantiated and misleading to consumers. The product claims to provide “measurable lift in just 8 weeks.”
  
Also in September, Christine A. Poon, J&J’s vice chairman, announced plans to retire on March 1, 2009 from the company and the board, after more than 23 years in the health care industry and eight years with the company.